Safety

Bearberry: Why Uva-Ursi Is Not A Daily Herb

Reviewed by Dr. Susan Vogler, DO, FACOG, MSCP

What bearberry is and where it comes from

Bearberry is Arctostaphylos uva-ursi, a low evergreen shrub found across the northern hemisphere. The leaf is the part used, which is what the FemiCore panel specifies when it prints “Bearberry (Arctostaphylos uva-ursi) (leaf)”. That specificity is worth noticing: the leaf is the traditional material and a label that names the plant part is being more precise than one that does not.

It has been used for urinary complaints in European herbal practice for a very long time, long enough that its use predates any understanding of bacteria. It is one of the few herbs in this aisle with a genuinely old and genuinely specific reputation rather than a general tonic one.

How arbutin is supposed to work

The active constituent is arbutin, a glycoside. Swallowed, it is metabolised and the products are excreted in the urine, where hydroquinone conjugates end up concentrated. A 2002 pharmacokinetic study measured exactly that excretion after oral administration of a standardised extract, in both a tablet and a solution.

Hydroquinone has antibacterial activity, so the traditional reasoning is coherent: a compound with antibacterial properties, concentrated in the urine, acting where the problem is. It is a better-reasoned mechanism than most herbal claims and it is supported by an actual measurement of where the compound goes.

But the mechanism and the caution are the same fact. The reason it might work is that hydroquinone reaches the urinary tract. The reason it is limited is that hydroquinone reaches the rest of you on the way.

Where the short-course tradition comes from

Herbal guidance on uva-ursi has been unusually consistent, and unusually restrictive, for a very long time. The general shape of it is a course of about a week at a time, repeated no more than a handful of times a year.

That is not how supplements in this aisle are sold. A supplement is sold as a daily habit in packs of one, three or six months, and the whole commercial model depends on continuous use. A traditional short-course herb inside a daily capsule is a genuine tension, and it is one that almost no label in the category acknowledges.

What the risk assessment actually assessed

This is where precision matters, because it is easy to overstate in either direction.

A risk assessment of free hydroquinone derived from Arctostaphylos uva-ursi folium herbal preparations was published in the International Journal of Toxicology in 2013. It exists because the question is real enough to warrant formal work, and the subject is free hydroquinone exposure from uva-ursi preparations rather than a single dose of the herb.

Two things follow, and both are important.

• The concern is cumulative. It is about exposure over time, which is precisely why the traditional guidance limits duration rather than dose.
• It concerns preparations with known content. A risk assessment works from a stated quantity. It cannot be applied to an undisclosed amount inside a blend, in either direction.

So this page will not tell you the bearberry in Femicore is dangerous, because that would require knowing how much is in it, and nobody outside the factory does. It will also not tell you the amount is too small to matter, for exactly the same reason. Both would be inventions, and inventing a reassurance is worse than inventing a warning.

The trial against an antibiotic, and what it found

Uva-ursi has been tested properly and recently, which is more than most of this aisle can say. A randomised controlled trial published in Clinical Microbiology and Infection in 2021 compared a standardised uva-ursi extract against fosfomycin in women presenting in primary care with uncomplicated urinary tract infection.

The herb did not prove a satisfactory substitute for the antibiotic. That is a useful result in two directions at once: it is real evidence about a real extract, and the direction it points is away from using this herb in place of treatment.

It also tells you something about dose. The trial used a standardised extract at a stated amount, because that is the only way to run a trial. A blend that prints neither cannot be compared with it.

Four of those five have an answer. The fifth is the one that would let a reader apply the other four.

What Femicore prints, and what it leaves out

The panel prints bearberry third of four in a 350 mg Herbal Blend, which under the labelling rules means it weighs less than the mimosa pudica and the cranberry and more than the berberine extract. That is the entire distribution disclosure.

It prints no duration limit at all. The suggested use is one capsule daily, and the product is sold in packs running to six months. Nothing on the bottle suggests a break, a maximum course or a reason to ask anyone.

This desk sells that product, which is exactly why this page exists. The practical position taken across this website is on the how to take it page: plan two months, which is what the guarantee covers, and take the duration question to a pharmacist before going further. It is also one of the reasons the pricing page recommends three bottles rather than six on a first order, and the desk earns less for saying so.

What to do if you are taking it anyway

1. Drink the water the label asks for. Six to eight ounces per capsule. On a bearberry product this is part of the mechanism rather than a swallowing aid.
2. Decide your course length before you start. Two months is a defensible plan because it matches the guarantee window and the review record. Deciding at the end of bottle four is not a plan.
3. Ask a pharmacist before going beyond that, with the panel in front of them. The berberine on the same label is the other reason to have that conversation, and it is set out on the side effects page.
4. Do not take it if you have kidney or liver disease without asking first.
5. Stop if symptoms appear or worsen. A supplement that is making something worse has answered the question you were asking it.

Why a proprietary blend makes the duration question worse

There is a second-order problem here that is easy to miss, and it is the reason this article exists rather than a one-line caution on a safety page.

Suppose the label printed “Bearberry leaf 40 mg”. A pharmacist could look at that, compare it against the amounts in the traditional guidance and in the risk assessment, and give you a view in about thirty seconds. The question would be answerable.

Instead the label prints a 350 mg blend containing four botanicals, with bearberry third by weight. That places it somewhere below cranberry and above the berberine extract, and nowhere more precise than that. A pharmacist asked whether the bearberry content warrants a duration limit cannot answer, because the only honest answer is that nobody outside the factory knows.

• If the amount is small, a long course is probably unremarkable, and nobody can confirm it is small.
• If the amount is meaningful, a six-month course is a question worth asking, and nobody can confirm it is meaningful.
• The proprietary blend does not resolve that in the product’s favour. It removes the ability to resolve it at all.

That is a general point about blends and this is the clearest example of it on the panel. A blend is usually discussed as a marketing problem, because it stops a buyer comparing a product against a trial. Here it is also a safety-information problem, because it stops a professional answering an ordinary question. Both are set out in the dose table on the ingredients page.

The wider problem this illustrates

Bearberry is a specific case of a general pattern worth recognising, because it will save you time on every other product in this aisle.

The supplement format wants a daily habit. Some traditional herbs were never used that way. Putting one inside a daily capsule does not change the herb, and a label that prints no duration limit has not resolved the tension so much as declined to mention it.

The test is quick. When you see a traditional herb on a daily supplement label, ask how it was traditionally used and for how long. If the traditional answer is a short course and the label says nothing, you have found a question the manufacturer has chosen not to answer. That is not always damning and it is always worth knowing, and it is one of the nine points on the checklist page.